| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
apolipoprotein E | 0.338 | 0.962 | 1.9E-03 |
|
disease | 0.700 | None | 0.966 | 6 | 0 | 1983 | 2019 | ||||||||
|
methylenetetrahydrofolate reductase | 0.337 | 0.885 | 3.2E-10 |
|
disease | 0.500 | None | 0.912 | 4 | 0 | 1991 | 2019 | ||||||||
|
phospholipase A2 group VII | 0.537 | 0.769 | 5.3E-22 |
|
disease | 0.500 | None | 0.975 | 3 | 0 | 1997 | 2019 | ||||||||
|
low density lipoprotein receptor | 0.449 | 0.885 | 9.8E-24 |
|
disease | 0.500 | None | 0.967 | 2 | 0 | 1986 | 2020 | ||||||||
|
apolipoprotein B | 0.453 | 0.808 | 1.9E-16 |
|
disease | 0.500 | None | 0.960 | 2 | 0 | 1986 | 2019 | ||||||||
|
lipoprotein(a) | 0.444 | 0.769 | 6.6E-89 |
|
disease | 0.500 | None | 0.968 | 2 | 0 | 1988 | 2019 | ||||||||
|
transcription factor 7 like 2 | 0.485 | 0.846 | 1.00 |
|
disease | 0.450 | None | 1.000 | 1 | 0 | 2008 | 2019 | ||||||||
|
paraoxonase 1 | 0.409 | 0.885 | 9.8E-11 |
|
disease | 0.400 | None | 0.938 | 7 | 0 | 1996 | 2019 | ||||||||
|
lipoprotein lipase | 0.474 | 0.808 | 1.3E-09 |
|
disease | 0.400 | None | 0.987 | 1 | 0 | 1993 | 2020 | ||||||||
|
angiotensin I converting enzyme | 0.328 | 0.923 | 1.0E-37 |
|
disease | 0.400 | None | 0.920 | 1 | 0 | 1992 | 2020 | ||||||||
|
CD36 molecule | 0.446 | 0.846 | 1.1E-60 |
|
disease | 0.400 | None | 1.000 | 1 | 0 | 1998 | 2019 | ||||||||
|
vitamin K epoxide reductase complex subunit 1 | 0.603 | 0.731 | 0.16 |
|
disease | 0.340 | None | 1.000 | 1 | 0 | 2006 | 2013 | ||||||||
|
matrix metallopeptidase 9 | 0.305 | 0.923 | 1.9E-17 |
|
disease | 0.300 | None | 0.971 | 2 | 0 | 2002 | 2019 | ||||||||
|
C-C motif chemokine receptor 5 (gene/pseudogene) | 0.398 | 0.885 | 4.3E-10 |
|
disease | 0.280 | None | 0.889 | 1 | 0 | 2004 | 2016 | ||||||||
|
CD40 ligand | 0.414 | 0.846 | 0.72 |
|
disease | 0.240 | None | 1.000 | 1 | 0 | 2008 | 2019 | ||||||||
|
macrophage migration inhibitory factor | 0.412 | 0.885 | 1.2E-02 |
|
disease | 0.230 | None | 1.000 | 1 | 0 | 2006 | 2015 | ||||||||
|
cholesteryl ester transfer protein | 0.512 | 0.731 | 1.2E-23 |
|
disease | 0.200 | None | 0.947 | 5 | 0 | 1990 | 2020 | ||||||||
|
ATP binding cassette subfamily A member 1 | 0.467 | 0.846 | 1.5E-13 |
|
disease | 0.200 | None | 0.960 | 5 | 0 | 2000 | 2019 | ||||||||
|
CDKN2B antisense RNA 1 | 0.491 | 0.769 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2007 | 2020 | |||||||||
|
proprotein convertase subtilisin/kexin type 9 | 0.482 | 0.808 | 2.7E-17 |
|
disease | 0.200 | None | 0.986 | 1 | 0 | 2006 | 2020 | ||||||||
|
potassium inwardly rectifying channel subfamily J member 11 | 0.529 | 0.615 | 1.1E-02 |
|
disease | 0.110 | None | 1.000 | 1 | 0 | 2006 | 2011 | ||||||||
|
C-reactive protein | 0.299 | 0.962 | 3.7E-03 |
|
disease | 0.100 | None | 0.933 | 11 | 0 | 1999 | 2020 | ||||||||
|
apolipoprotein A5 | 0.587 | 0.615 | 5.6E-10 |
|
disease | 0.100 | None | 0.927 | 4 | 0 | 2001 | 2019 | ||||||||
|
adiponectin, C1Q and collagen domain containing | 0.376 | 0.885 | 4.6E-09 |
|
disease | 0.100 | None | 0.946 | 3 | 0 | 2000 | 2019 | ||||||||
|
apolipoprotein A4 | 0.582 | 0.577 | 5.5E-06 |
|
disease | 0.100 | None | 0.900 | 3 | 0 | 1996 | 2015 |